Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Pettersson Bergstrand, Madeleine"'
Publikováno v:
In Clinical Mass Spectrometry December 2018 10:25-32
Publikováno v:
In Journal of Chromatography B 1 November 2016 1035:104-110
Autor:
Bäckberg, Matilda1 mat.backberg@gmail.com, Pettersson Bergstrand, Madeleine2,3, Beck, Olof2,4, Helander, Anders2,3,4
Publikováno v:
Clinical Toxicology (15563650). Mar2019, Vol. 57 Issue 3, p203-212. 10p.
Autor:
Arvidsson, Michel, Franck, Johan, Ackehed, Gerd, Pettersson Bergstrand, Madeleine, Ekström, Lena, Rosenborg, Staffan, Dahl, Marja‐Liisa
Publikováno v:
Basic & Clinical Pharmacology & Toxicology; Apr2022, Vol. 130 Issue 4, p492-500, 9p
Autor:
Pettersson Bergstrand, Madeleine, Richter, Lilian H. J., Maurer, Hans H., Wagmann, Lea, Meyer, Markus R.
Publikováno v:
Drug Testing & Analysis; Jan/Feb2019, Vol. 11 Issue 1, p45-50, 6p
Publikováno v:
Drug Testing & Analysis; Mar2018, Vol. 10 Issue 3, p496-506, 11p
Publikováno v:
Drug Testing & Analysis; Apr2017, Vol. 9 Issue 4, p640-645, 6p
Autor:
Soeria‐Atmadja, Sandra1,2 (AUTHOR) sandra.soeria-atmadja@ki.se, Amuge, Pauline3 (AUTHOR), Nanzigu, Sarah4 (AUTHOR), Bbuye, Dickson3 (AUTHOR), Eriksen, Jaran5,6 (AUTHOR), Rubin, Johanna1,2 (AUTHOR), Kekitiinwa, Adeodata3 (AUTHOR), Obua, Celestino7 (AUTHOR), Dahl, Marja‐Liisa8,9 (AUTHOR), Pettersson Bergstrand, Madeleine8,9 (AUTHOR), Pohanka, Anton8,9 (AUTHOR), Gustafsson, Lars L.8 (AUTHOR), Navér, Lars1,2 (AUTHOR)
Publikováno v:
British Journal of Clinical Pharmacology. Oct2024, p1. 15p. 2 Illustrations.
Autor:
Wagmann, Lea, Richter, Lilian, Kehl, Tobias, Wack, Franziska, Pettersson Bergstrand, Madeleine, Brandt, Simon D., Stratford, Simon, Maurer, Hans H., Meyer, Markus
The market of new psychoactive substances (NPS) is characterized by a high turnover and thus provides several challenges for analytical toxicology. The analysis of urine samples often requires detailed knowledge about metabolism given that parent com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc8de7d3c90299a6919ef52e417c5b7
https://researchonline.ljmu.ac.uk/id/eprint/9841/13/ABC-01967-2018_02_accepted.pdf
https://researchonline.ljmu.ac.uk/id/eprint/9841/13/ABC-01967-2018_02_accepted.pdf
Autor:
Pettersson Bergstrand M; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Soeria-Atmadja S; Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden; and.; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden., Barclay V; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Tolic J; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden., Navér L; Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden; and.; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden., Gustafsson LL; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Pohanka A; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Aug 01; Vol. 46 (4), pp. 468-476. Date of Electronic Publication: 2024 Jun 11.